263 related articles for article (PubMed ID: 8261406)
1. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
2. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Zhang QX; Borg A; Fuqua SA
Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
[TBL] [Abstract][Full Text] [Related]
3. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
6. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
Fasco MJ
Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
[TBL] [Abstract][Full Text] [Related]
9. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells.
Rea D; Parker MG
Cancer Res; 1996 Apr; 56(7):1556-63. PubMed ID: 8603402
[TBL] [Abstract][Full Text] [Related]
10. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.
Park W; Choi JJ; Hwang ES; Lee JH
Clin Cancer Res; 1996 Dec; 2(12):2029-35. PubMed ID: 9816163
[TBL] [Abstract][Full Text] [Related]
11. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.
Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors.
Poola I; Williams DM; Koduri S; Ramprakash J; Taylor RE; Hankins WD
Anal Biochem; 1998 May; 258(2):209-15. PubMed ID: 9570831
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
14. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
[TBL] [Abstract][Full Text] [Related]
15. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
16. A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.
van Dijk MA; Floore AN; Kloppenborg KI; van 't Veer LJ
Cancer Res; 1997 Aug; 57(16):3478-85. PubMed ID: 9270016
[TBL] [Abstract][Full Text] [Related]
17. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]